BioSpace News Archive

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer and castrate-resistant prostate cancer, today announced that it will host a key opinion leader (KOL) webinar on onvansertib for the treatment of KRAS-mutated metastatic colorectal cancer

Abbott (NYSE: ABT) today announced it has received CE Mark for its next-generation TriClip™ Transcatheter Tricuspid Valve Repair System, the first-of-its-kind minimally invasive tricuspid heart valve repair device available in Europe to treat tricuspid regurgitation (TR)

SightCall, an augmented reality (AR)-powered visual assistance platform, today announced its partnership with Stago Group, a multinational developer of haemostasis solutions for diagnostic laboratories

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics solutions company, today announced that it has received a notice of allowance (‘Letter of Intent to Grant a Patent’) from the European Patent Office covering the use of the Company’s proprietary Total Biochemical Infrared Analysis (‘TBIA’) method that uses blood (plasma and/or peripheral blood mononuclear cells ‘PBMCs’)

On the back of a successful partnership that started just over one year ago, the owners of Prince Premium+ Nitrile Exam Gloves (GIS RESOURCES SDN BHD) announced a distribution agreement with Tristate Medical Supplies - a leading distributor of medical supplies to the United States Government.

Together, Helix and Ginkgo will make easy, affordable, pooled COVID-19 testing accessible to teachers, staff, and students in these communities

2020, a record year with revenue of €13.5m, up 51% on 2019 2020 results in line with expectations Acceleration of the growth dynamic in the first quarter of 2021 with revenue of €5.2m, an increase of 86% compared to Q1, 2020.

Building on three years of success, the American Diabetes Association announced a new partnership with Yumlish, a virtual service platform, as part of the ADA’s work on the National Diabetes Prevention Program.

Onxeo S.A. (Euronext Growth Paris: ALONX, First North Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), today announced the presentation of preclinical data confirming the differentiated antitumoral properties of the drug candidates generated by platON™

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 first quarter results for Tuesday, May 4, 2021 before the market opens.